0.014428
0.000000
0.000000
0.000000
0.043122
0.000000
0.000000
0.000000
0.034200
0.00000
0.00000
0.00000
TWO ALTERNATE CONFORMATIONS ARE GIVEN FOR THE SIDE CHAIN OF GLU 7.
Danishefsky, A.T.
Wlodawer, A.
Kim, K.-S.
Tao, F.
Woodward, C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
90.00
90.00
69.310
23.190
29.240
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Protein Sci.
PRCIEI
0795
0961-8368
2
577
587
8518731
Crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of F22A, Y23A, N43G, and F45A.
1993
US
Protein Sci.
PRCIEI
0795
0961-8368
2
588
Crevice-Forming Mutants of Bovine Pancreatic Trypsin Inhibitor: Stability Changes and New Hydrophobic Surface
1993
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
220
757
Crystal Structure of a Y35G Mutant of Bovine Pancreatic Trypsin Inhibitor
1991
UK
Protein Eng.
PRENE9
0859
0269-2139
3
591
Structural Effects Induced by Removal of a Disulfide-Bridge. The X-Ray Structure of the C30A(Slash)C51A Mutant of Basic Pancreatic Trypsin Inhibitor at 1.6 Angstroms
1990
US
Biochemistry
BICHAW
0033
0006-2960
29
10018
X-Ray Crystal Structure of the Protease Inhibitor Domain of Alzheimer'S Amyloid Beta-Protein Precursor
1990
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
198
469
Structure of Form III Crystals of Bovine Pancreatic Trypsin Inhibitor
1987
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
193
145
Comparison of Two Highly Refined Structures of Bovine Pancreatic Trypsin Inhibitor
1987
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
180
301
Structure of Bovine Pancreatic Trypsin Inhibitor. Results of Joint Neutron and X-Ray Refinement of Crystal Form II
1984
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
167
911
Pancreatic Trypsin Inhibitor. A New Crystal Form and its Analysis
1983
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
x-ray
1
1.0
6451.472
BOVINE PANCREATIC TRYPSIN INHIBITOR
1
man
polymer
18.015
water
56
nat
water
no
no
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNAKSAEDCMRTCGGA
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNAKSAEDCMRTCGGA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
sample
9913
Bos taurus
1.82
32.42
pdbx_database_status
software
software
repository
Initial release
Version format compliance
Version format compliance
Data collection
Other
Refinement description
Data collection
Refinement description
1
0
1993-10-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2019-07-17
1
4
2019-08-14
_pdbx_database_status.process_site
_software.classification
_software.classification
Y
BNL
1992-08-21
REL
REL
HOH
water
HOH
70
2
HOH
HOH
70
A
HOH
102
2
HOH
HOH
102
A
HOH
110
2
HOH
HOH
110
A
HOH
111
2
HOH
HOH
111
A
HOH
112
2
HOH
HOH
112
A
HOH
113
2
HOH
HOH
113
A
HOH
117
2
HOH
HOH
117
A
HOH
119
2
HOH
HOH
119
A
HOH
122
2
HOH
HOH
122
A
HOH
126
2
HOH
HOH
126
A
HOH
127
2
HOH
HOH
127
A
HOH
129
2
HOH
HOH
129
A
HOH
133
2
HOH
HOH
133
A
HOH
134
2
HOH
HOH
134
A
HOH
138
2
HOH
HOH
138
A
HOH
140
2
HOH
HOH
140
A
HOH
143
2
HOH
HOH
143
A
HOH
145
2
HOH
HOH
145
A
HOH
156
2
HOH
HOH
156
A
HOH
157
2
HOH
HOH
157
A
HOH
158
2
HOH
HOH
158
A
HOH
160
2
HOH
HOH
160
A
HOH
203
2
HOH
HOH
203
A
HOH
205
2
HOH
HOH
205
A
HOH
214
2
HOH
HOH
214
A
HOH
218
2
HOH
HOH
218
A
HOH
220
2
HOH
HOH
220
A
HOH
223
2
HOH
HOH
223
A
HOH
302
2
HOH
HOH
302
A
HOH
311
2
HOH
HOH
311
A
HOH
312
2
HOH
HOH
312
A
HOH
313
2
HOH
HOH
313
A
HOH
314
2
HOH
HOH
314
A
HOH
317
2
HOH
HOH
317
A
HOH
319
2
HOH
HOH
319
A
HOH
400
2
HOH
HOH
400
A
HOH
401
2
HOH
HOH
401
A
HOH
402
2
HOH
HOH
402
A
HOH
403
2
HOH
HOH
403
A
HOH
404
2
HOH
HOH
404
A
HOH
405
2
HOH
HOH
405
A
HOH
406
2
HOH
HOH
406
A
HOH
407
2
HOH
HOH
407
A
HOH
408
2
HOH
HOH
408
A
HOH
409
2
HOH
HOH
409
A
HOH
410
2
HOH
HOH
410
A
HOH
411
2
HOH
HOH
411
A
HOH
412
2
HOH
HOH
412
A
HOH
413
2
HOH
HOH
413
A
HOH
414
2
HOH
HOH
414
A
HOH
415
2
HOH
HOH
415
A
HOH
416
2
HOH
HOH
416
A
HOH
417
2
HOH
HOH
417
A
HOH
418
2
HOH
HOH
418
A
HOH
419
2
HOH
HOH
419
A
HOH
420
2
HOH
HOH
420
A
ARG
1
n
1
ARG
1
A
PRO
2
n
2
PRO
2
A
ASP
3
n
3
ASP
3
A
PHE
4
n
4
PHE
4
A
CYS
5
n
5
CYS
5
A
LEU
6
n
6
LEU
6
A
GLU
7
n
7
GLU
7
A
PRO
8
n
8
PRO
8
A
PRO
9
n
9
PRO
9
A
TYR
10
n
10
TYR
10
A
THR
11
n
11
THR
11
A
GLY
12
n
12
GLY
12
A
PRO
13
n
13
PRO
13
A
CYS
14
n
14
CYS
14
A
LYS
15
n
15
LYS
15
A
ALA
16
n
16
ALA
16
A
ARG
17
n
17
ARG
17
A
ILE
18
n
18
ILE
18
A
ILE
19
n
19
ILE
19
A
ARG
20
n
20
ARG
20
A
TYR
21
n
21
TYR
21
A
PHE
22
n
22
PHE
22
A
TYR
23
n
23
TYR
23
A
ASN
24
n
24
ASN
24
A
ALA
25
n
25
ALA
25
A
LYS
26
n
26
LYS
26
A
ALA
27
n
27
ALA
27
A
GLY
28
n
28
GLY
28
A
LEU
29
n
29
LEU
29
A
CYS
30
n
30
CYS
30
A
GLN
31
n
31
GLN
31
A
THR
32
n
32
THR
32
A
PHE
33
n
33
PHE
33
A
VAL
34
n
34
VAL
34
A
TYR
35
n
35
TYR
35
A
GLY
36
n
36
GLY
36
A
GLY
37
n
37
GLY
37
A
CYS
38
n
38
CYS
38
A
ARG
39
n
39
ARG
39
A
ALA
40
n
40
ALA
40
A
LYS
41
n
41
LYS
41
A
ARG
42
n
42
ARG
42
A
ASN
43
n
43
ASN
43
A
ASN
44
n
44
ASN
44
A
ALA
45
n
45
ALA
45
A
LYS
46
n
46
LYS
46
A
SER
47
n
47
SER
47
A
ALA
48
n
48
ALA
48
A
GLU
49
n
49
GLU
49
A
ASP
50
n
50
ASP
50
A
CYS
51
n
51
CYS
51
A
MET
52
n
52
MET
52
A
ARG
53
n
53
ARG
53
A
THR
54
n
54
THR
54
A
CYS
55
n
55
CYS
55
A
GLY
56
n
56
GLY
56
A
GLY
57
n
57
GLY
57
A
ALA
58
n
58
ALA
58
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
TYR
35
A
O
TYR
35
A
N
ILE
18
A
N
ILE
18
A
O
TYR
21
A
O
TYR
21
A
N
ALA
45
A
N
ALA
45
1
4.59
0.50
120.30
124.89
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
1
1
1
N
1
13.81
2.20
113.40
127.21
A
A
A
CA
CB
CG
GLU
GLU
GLU
7
7
7
A
A
N
1
12.85
2.00
118.30
131.15
A
A
A
CG
CD
OE1
GLU
GLU
GLU
7
7
7
A
A
A
N
1
-3.96
0.50
120.30
116.34
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
17
17
17
N
1
3.21
0.50
120.30
123.51
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
39
39
39
N
1
-3.36
0.50
120.30
116.94
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
39
39
39
N
1
-4.20
0.50
120.30
116.10
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
53
53
53
N
DENSITY FOR 2 CARBOXY-TERMINAL RESIDUES (GLY 57, ALA 58)
WAS UNCLEAR IN THE FINAL MAPS AND TEMPERATURE FACTORS ARE
HIGH FOR THIS REGION.
0.169
0.169
2.0
10.0
3395
1
1.0
2.0
10.0
56
509
0
0
453
0.015
2.399
3.0
3.212
3.5
3.888
4.0
5.596
5.0
model building
X-PLOR
refinement
PROLSQ
refinement
X-PLOR
phasing
X-PLOR
BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH PHE 45 REPLACED BY ALA (F45A)
CREVICE-FORMING MUTANTS IN THE RIGID CORE OF BOVINE PANCREATIC TRYPSIN INHIBITOR: CRYSTAL STRUCTURES OF F22A, Y23A, N43G, AND F45A
1
N
N
2
N
N
A
PRO
2
A
PRO
2
HELX_P
A
GLU
7
A
GLU
7
5
H1
6
A
SER
47
A
SER
47
HELX_P
A
GLY
56
A
GLY
56
1
H2
10
disulf
1.982
A
CYS
5
A
SG
CYS
5
1_555
A
CYS
55
A
SG
CYS
55
1_555
disulf
2.063
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
1.982
A
CYS
30
A
SG
CYS
30
1_555
A
CYS
51
A
SG
CYS
51
1_555
SERINE PROTEASE INHIBITOR
SERINE PROTEASE INHIBITOR
BPT1_BOVIN
UNP
1
1
P00974
MKMSRLCLSVALLVLLGTLAASTPGCDTSNQAKAQRPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNF
KSAEDCMRTCGGAIGPWENL
36
93
1FAN
1
58
P00974
A
1
1
58
1
PHE
CONFLICT
ALA
45
1FAN
A
P00974
UNP
80
45
3
anti-parallel
anti-parallel
A
LEU
29
A
LEU
29
A
TYR
35
A
TYR
35
A
ILE
18
A
ILE
18
A
ASN
24
A
ASN
24
A
ALA
45
A
ALA
45
A
ALA
45
A
ALA
45
19
P 21 21 21